Victor Shi
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
-
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
Papers in
-
- Heart Failure Treatment and Management 70
- Cardiovascular Function and Risk Factors 23
- Blood Pressure and Hypertension Studies 16
- Cardiac pacing and defibrillation studies 6
- Cardiac electrophysiology and arrhythmias 4
-
- Diabetes Treatment and Management 8
- Hormonal Regulation and Hypertension 4
- Co-authors
- John J.V. McMurray (91 shared papers)Scott D. Solomon (89 shared papers)Milton Packer (76 shared papers)Michael R. Zile (78 shared papers)Martin Lefkowitz (84 shared papers)Jean L. Rouleau (65 shared papers)Karl Swedberg (55 shared papers)Akshay S. Desai (44 shared papers)
- Journals
- Journal of the American College of Cardiology (24 papers)European Journal of Heart Failure (20 papers)Circulation Heart Failure (10 papers)Circulation (9 papers)Journal of Cardiac Failure (8 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Victor Shi
117 papers receiving 13.2k citations
Victor Shi's Hit Papers
Peers
Comparison fields: 5 of 126
- Cardiology and Cardiovascular Medicine 10.3k
- Endocrinology, Diabetes and Metabolism 2.4k
- Nephrology 446
- Family Practice 109
- Pulmonary and Respiratory Medicine 1.6k
Countries citing papers authored by Victor Shi
This map shows the geographic impact of Victor Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Shi more than expected).
Fields of papers citing papers by Victor Shi
This network shows the impact of papers produced by Victor Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Shi. The network helps show where Victor Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Victor Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure Hit paper breakdown → | 2014 | 4433 |
| 2 | Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients Hit paper breakdown → | 2008 | 1315 |
| 3 | The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial Hit paper breakdown → | 2012 | 890 |
| 4 | Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF) Hit paper breakdown → | 2013 | 342 |
| 5 | 2010 | 317 | |
| 6 | Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients Hit paper breakdown → | 2015 | 302 |
| 7 | Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure Hit paper breakdown → | 2018 | 293 |
| 8 | 2016 | 248 | |
| 9 | 2016 | 248 | |
| 10 | 2017 | 241 | |
| 11 | 2014 | 198 | |
| 12 | 2019 | 195 | |
| 13 | 2015 | 177 | |
| 14 | 2016 | 173 | |
| 15 | 2016 | 159 | |
| 16 | 2016 | 153 | |
| 17 | 2017 | 151 | |
| 18 | 2016 | 149 | |
| 19 | 2019 | 144 | |
| 20 | 2015 | 143 |
About Victor Shi
Victor Shi is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Surgery and Nephrology, having authored 120 papers that have together received 13.6k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (70 papers), Cardiovascular Function and Risk Factors (23 papers), Blood Pressure and Hypertension Studies (16 papers), Diabetes Treatment and Management (8 papers), Cardiac pacing and defibrillation studies (6 papers), Potassium and Related Disorders (5 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Hormonal Regulation and Hypertension (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (10.3k citations), Endocrinology, Diabetes and Metabolism (2.4k citations), Nephrology (446 citations), Family Practice (109 citations) and Pulmonary and Respiratory Medicine (1.6k citations). Victor Shi has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John J.V. McMurray, Scott D. Solomon, Milton Packer, Michael R. Zile, Martin Lefkowitz, Jean L. Rouleau, Karl Swedberg, Akshay S. Desai, Jianjian Gong and Adel R. Rizkala. Their work appears in journals such as Journal of the American College of Cardiology, European Journal of Heart Failure, Circulation Heart Failure, Circulation and Journal of Cardiac Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.